164 related articles for article (PubMed ID: 37845287)
1. A radiomics model based on magnetic resonance imaging to predict cytokeratin 7/19 expression and liver fluke infection of hepatocellular carcinoma.
Liu JQ; Wang J; Huang XL; Liang TY; Zhou X; Mo ST; Xie HX; Yang KJ; Zhu GZ; Su H; Liao XW; Long LL; Peng T
Sci Rep; 2023 Oct; 13(1):17553. PubMed ID: 37845287
[TBL] [Abstract][Full Text] [Related]
2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
3. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Chen Y; Chen J; Zhang Y; Lin Z; Wang M; Huang L; Huang M; Tang M; Zhou X; Peng Z; Huang B; Feng ST
J Hepatocell Carcinoma; 2021; 8():795-808. PubMed ID: 34327180
[TBL] [Abstract][Full Text] [Related]
6. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence.
Uenishi T; Kubo S; Yamamoto T; Shuto T; Ogawa M; Tanaka H; Tanaka S; Kaneda K; Hirohashi K
Cancer Sci; 2003 Oct; 94(10):851-7. PubMed ID: 14556657
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
[TBL] [Abstract][Full Text] [Related]
10. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
[TBL] [Abstract][Full Text] [Related]
11. A radiomics nomogram for predicting cytokeratin 19-positive hepatocellular carcinoma: a two-center study.
Zhang L; Zhou H; Zhang X; Ding Z; Xu J
Front Oncol; 2023; 13():1174069. PubMed ID: 37182122
[TBL] [Abstract][Full Text] [Related]
12. Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy.
Qin SD; Zhang J; Qi YP; Zhong JH; Xiang BD
World J Surg Oncol; 2022 Jun; 20(1):209. PubMed ID: 35725470
[TBL] [Abstract][Full Text] [Related]
13. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis.
Qin Q; Deng LP; Chen J; Ye Z; Wu YY; Yuan Y; Song B
Clin Radiol; 2023 Dec; 78(12):e975-e984. PubMed ID: 37783612
[TBL] [Abstract][Full Text] [Related]
14. CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.
Liu LZ; Yang LX; Zheng BH; Dong PP; Liu XY; Wang ZC; Zhou J; Fan J; Wang XY; Gao Q
J Surg Oncol; 2018 Jun; 117(7):1531-1539. PubMed ID: 29513894
[TBL] [Abstract][Full Text] [Related]
15. [Expression of cytokeratin(CK)7, CK8/18, CK19 and p40 in esophageal squamous cell carcinoma and their correlation with prognosis].
Yang ZY; Zhang HY; Wang F; Ma YH; Li YY; He HL; Wang C; Li SS
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):834-839. PubMed ID: 30423606
[No Abstract] [Full Text] [Related]
16. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
Lee SH; Lee JS; Na GH; You YK; Kim DG
Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27653235
[TBL] [Abstract][Full Text] [Related]
17. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
Front Oncol; 2021; 11():672126. PubMed ID: 34476208
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
19. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
20. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas.
Hu XX; Wang WT; Yang L; Yang ZX; Liang HY; Ding Y; Ji Y; Zeng MS; Rao SX
Eur J Radiol; 2019 Apr; 113():7-14. PubMed ID: 30927962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
